Santa Barbara Luncheon Series - Amgen - Biotechnology Pioneer
|
APR
04
|
|
||||||||||||||||||||||
A Santa Barbara Group Sponsored Event
An assortment of sandwiches, salads, and drinks will be provided.
David W. Meline will give you an overview of Amgen and the risks & opportunities for the company in today’s challenging environment. David will walk you through the recent development and the likely future of therapeutics, biosimilar, personalized medicine as well as other major developments in the pharmaceutical and biotechnology industry. He will talk about roadblocks to the drug development & discovery process and the potential political impact of the new Trump administration especially in light of the recent debate about pharmaceuticals prices.
David W. Meline | David Meline joined Amgen in 2014 as executive vice president and chief financial officer. Meline is responsible for Amgen’s finance, information systems, global business services and investor relations.
Prior to Amgen, Meline was senior vice president and chief financial officer at 3M. Before joining 3M, Meline had been at General Motors, serving in various capacities including vice president and chief financial officer for GM North America. He had also held senior-level positions with GM Europe in Switzerland, GM Daewoo in South Korea, GM Brasil, GM Kenya, and at GM’s New York office in the company’s treasurer’s office. Meline began his career at AT&T Corporation as a product design engineer.
Meline is a member of the board of directors of ABB (ASEA Brown Boveri), a Swiss multinational firm, and the Los Angeles Philharmonic.
He holds a Bachelor of Science in mechanical engineering from Iowa State University, a Master of Science in economics from the London School of Economics, London, United Kingdom, and an MBA in finance from the University of Chicago. Back To Top ^^
An assortment of sandwiches, salads, and drinks will be provided.
David W. Meline will give you an overview of Amgen and the risks & opportunities for the company in today’s challenging environment. David will walk you through the recent development and the likely future of therapeutics, biosimilar, personalized medicine as well as other major developments in the pharmaceutical and biotechnology industry. He will talk about roadblocks to the drug development & discovery process and the potential political impact of the new Trump administration especially in light of the recent debate about pharmaceuticals prices.
David W. Meline | David Meline joined Amgen in 2014 as executive vice president and chief financial officer. Meline is responsible for Amgen’s finance, information systems, global business services and investor relations.Prior to Amgen, Meline was senior vice president and chief financial officer at 3M. Before joining 3M, Meline had been at General Motors, serving in various capacities including vice president and chief financial officer for GM North America. He had also held senior-level positions with GM Europe in Switzerland, GM Daewoo in South Korea, GM Brasil, GM Kenya, and at GM’s New York office in the company’s treasurer’s office. Meline began his career at AT&T Corporation as a product design engineer.
Meline is a member of the board of directors of ABB (ASEA Brown Boveri), a Swiss multinational firm, and the Los Angeles Philharmonic.
He holds a Bachelor of Science in mechanical engineering from Iowa State University, a Master of Science in economics from the London School of Economics, London, United Kingdom, and an MBA in finance from the University of Chicago. Back To Top ^^
| Registration Fees $5 (Members) | $20 (Non-Members) |
Payment Information
We accept the following:
If you prefer to pay by check please register online and select "purchase order" as your payment option and enter your last name as the purchase order number.
We accept the following:
If you prefer to pay by check please register online and select "purchase order" as your payment option and enter your last name as the purchase order number.
Mail check to:
CFA Society of Los Angeles, 520 S. Grand Ave, Suite 655, Los Angeles CA 90071.
*Credit card payments will only be accepted through the secure online registration, and not by phone or email.
Cancellations
Cancellations must be received in writing by 9:00 am the day prior to the event to receive a refund. No phone cancellations are accepted. Please fax to the CFALA office at (213) 613-1233 or e-mail info@cfala.org. Member “no-shows” will be billed the difference between the member fee and the non-member fee for the event which is posted on the CFALA website.
Cancellations must be received in writing by 9:00 am the day prior to the event to receive a refund. No phone cancellations are accepted. Please fax to the CFALA office at (213) 613-1233 or e-mail info@cfala.org. Member “no-shows” will be billed the difference between the member fee and the non-member fee for the event which is posted on the CFALA website.
Chairs:
Falko Hörnicke, CFA®, CFP® & George Tharakan, CFA
Falko Hörnicke, CFA®, CFP® & George Tharakan, CFA
 |
As a participant in the CFA Institute Approved-Provider Program, the CFA Society of Los Angeles has determined that this program qualifies for 1 credit hours. If you are a CFA Institute member, CE credit for your participation in this program will be automatically recorded in your CE Diary. |
